Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251492 | 12625149 | 2 | F | 201606 | 20160830 | 20160805 | 20160912 | EXP | IT-TEVA-680701ACC | TEVA | 57.50 | YR | F | Y | 0.00000 | 20160912 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251492 | 12625149 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | N | 20622 | INJECTION | TIW | ||||||||
| 126251492 | 12625149 | 2 | C | LIORESAL | BACLOFEN | 1 | Oral | 0 | TID | ||||||||||
| 126251492 | 12625149 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126251492 | 12625149 | 1 | Multiple sclerosis |
| 126251492 | 12625149 | 3 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126251492 | 12625149 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126251492 | 12625149 | Fatigue | |
| 126251492 | 12625149 | Hyperglycaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126251492 | 12625149 | 1 | 201605 | 201606 | 0 | |
| 126251492 | 12625149 | 2 | 2007 | 0 |